• Cardio Diagnostics will hold its annual shareholder meeting virtually on Sept. 18, 2026.
• Shareholders will vote on electing seven directors, including Meeshanthini V. Dogan and Warren Hosseinion.
• A proposal seeks authorization for a future non-public issuance of common stock or related securities of at least 20% of shares outstanding.
• Shareholders will also vote on ratifying Prager Metis CPAs as independent auditor for the year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardio Diagnostics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001079973-26-000945), on July 13, 2026, and is solely responsible for the information contained therein.